Stanley Wang

2.4k citations

28 papers · 898 indexed · h-index 13

Impact in

Hepatology top 2%
- Hepatitis C virus research
Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies

Papers in ⓘ

Hepatology 20
- Hepatitis C virus research 19
Infectious Diseases 13
- HIV/AIDS drug development and treatment 10

Co-authors: Amy E. Wallace (2 shared papers)Lewis E. Kazis (2 shared papers)William B. Weeks (2 shared papers)Austin F. Lee (1 shared paper)Federico Mensa (16 shared papers)Austin Lee (1 shared paper)Shirit Einav (3 shared papers)Edward Tam (5 shared papers)
Journals: Gastroenterology (6 papers)Journal of Hepatology (4 papers)Open Forum Infectious Diseases (2 papers)Clinical Infectious Diseases (1 paper)Blood (1 paper)
Partner nations: United States Canada France

In The Last Decade

Stanley Wang

27 papers receiving 870 citations

Peers

Countries citing papers authored by Stanley Wang

Since Specialization

Citations

This map shows the geographic impact of Stanley Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanley Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanley Wang more than expected).

Fields of papers citing papers by Stanley Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stanley Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanley Wang. The network helps show where Stanley Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Stanley Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stanley Wang Line = papers co-authored together Stanley Wang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects Journal of Clinical Investigation ·Elena Bekerman, Grégory Neveu, Ana Shulla, Jennifer M. Brannan, Szu‐Yuan Pu, Stanley Wang, Fei Xiao, Rina Barouch‐Bentov, Russell R. Bakken, Roberto Mateo, Jennifer Govero, Claude M. Nagamine, Michael Diamond, Steven De Jonghe, Piet Herdewijn, John M. Dye, Glenn Randall, Shirit Einav	2017	172
2	Rural and Urban Disparities in Health-Related Quality of Life Among Veterans With Psychiatric Disorders Psychiatric Services ·Amy E. Wallace, William B. Weeks, Stanley Wang, Austin F. Lee, Lewis E. Kazis	2006	113
3	High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1–6 patients without cirrhosis Journal of Hepatology ·Massimo Puoti, Graham R. Foster, Stanley Wang, David Mutimer, Edward Gane, Christophe Moreno, Ting Chang, Samuel S. Lee, Rui Marinho, Jean‐François Dufour, Stanislas Pol, Christophe Hézode, Stuart C. Gordon, Simone I. Strasser, Paul J. Thuluvath, Zhenzhen Zhang, Sandra Lovell, Edward Tam, Federico Mensa	2018	112
4	Rural‐Urban Disparities in Health‐Related Quality of Life Within Disease Categories of Veterans The Journal of Rural Health ·William B. Weeks, Amy E. Wallace, Stanley Wang, Austin Lee, Lewis E. Kazis	2006	109
5	Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial Hepatology ·David Wyles, Fred Poordad, Stanley Wang, Laurent Alric, Franco Felizarta, Paul Y. Kwo, Benedict Maliakkal, Kosh Agarwal, Tarek Hassanein, Frank Weilert, Samuel S. Lee, Jens Kort, Sandra Lovell, Ran Liu, Chih-Wei Lin, Edward Tam, Preethi Krishnan, Federico Mensa	2017	99
6	High Efficacy of ABT-493 and ABT-530 Treatment in Patients With HCV Genotype 1 or 3 Infection and Compensated Cirrhosis Gastroenterology ·Edward Gane, Fred Poordad, Stanley Wang, Armen Asatryan, Paul Y. Kwo, Jacob Lalezari, David Wyles, Tarek Hassanein, Humberto Aguilar, Benedict Maliakkal, Ran Liu, Chih-Wei Lin, Teresa I. Ng, Jens Kort, Federico Mensa	2016	72
7	B-cell receptors expressed by lymphomas of hepatitis C virus (HCV)–infected patients rarely react with the viral proteins Blood ·Patrick P. Ng, Chiung-Chi Kuo, Stanley Wang, Shirit Einav, Luca Arcaini, Marco Paulli, Carol S. Portlock, Joseph Marcotrigiano, Alexander W. Tarr, Jonathan K. Ball, Ronald Levy, Shoshana Levy	2014	34
8	Interactions between the Hepatitis C Virus Nonstructural 2 Protein and Host Adaptor Proteins 1 and 4 Orchestrate Virus Release mBio ·Fei Xiao, Stanley Wang, Rina Barouch‐Bentov, Grégory Neveu, Szu‐Yuan Pu, Beer Melanie, Stanford Schor, Sathish Kumar, Vlad Nicolaescu, Brett D. Lindenbach, Glenn Randall, Shirit Einav	2018	30
9	Glecaprevir/pibrentasvir in patients with chronic HCV and recent drug use: An integrated analysis of 7 phase III studies Drug and Alcohol Dependence ·Graham R. Foster, Gregory J. Dore, Stanley Wang, Jason Grebely, Kenneth E. Sherman, Axel Baumgarten, Brian Conway, Daniel Jackson, Tarik Asselah, Michael Gschwantler, Krzysztof Tomasiewicz, Humberto Aguilar, Armen Asatryan, Yiran Hu, Federico Mensa	2018	29
10	Telephone Triage Service Data for Detection of Influenza-Like Illness PLoS ONE ·W. Katherine Yih, Kathryn S. Teates, Allyson Abrams, Ken Kleinman, Martin Kulldorff, Robert W. Pinner, Robert Harmon, Stanley Wang, Richard Platt	2009	24
11	Safety and Pharmacokinetics of Glecaprevir/Pibrentasvir in Adults With Chronic Genotype 1–6 Hepatitis C Virus Infections and Compensated Liver Disease Clinical Infectious Diseases ·Edward Gane, Fred Poordad, Neddie Zadeikis, Joaquin Valdes, Chih-Wei Lin, Wei Liu, Armen Asatryan, Stanley Wang, Catherine Stedman, Susan Greenbloom, Tuan Nguyen, Magdy Elkhashab, Marcus‐Alexander Wörns, Albert Tran, Jean-Pierre Mulkay, Carolyn M. Setze, Yao Yu, Edward Tam, Ariel Porcalla, Federico Mensa	2019	23
12	Excretion of urine extracellular vesicles bearing markers of activated immune cells and calcium/phosphorus physiology differ between calcium kidney stone formers and non-stone formers BMC Nephrology ·Jiqing Zhang, Sanjay Kumar, Muthuvel Jayachandran, Loren P. Herrera Hernandez, Stanley Wang, Elena Wilson, John C. Lieske	2021	18
13	Drug-Drug Interactions of Glecaprevir and Pibrentasvir Coadministered With Human Immunodeficiency Virus Antiretrovirals The Journal of Infectious Diseases ·Matthew P. Kosloski, Rajneet K. Oberoi, Stanley Wang, Rolando M. Viani, Armen Asatryan, Beibei Hu, Bifeng Ding, Xin Qi, Elaine J. Kim, Federico Mensa, Jens Kort, Wei Liu	2019	14
14	COCATS 4 Task Force 2: Training in Preventive Cardiovascular Medicine Journal of the American College of Cardiology ·Sidney C. Smith, Vera Bittner, J. Michael Gaziano, John C. Giacomini, Quinn R. Pack, Donna M. Polk, Neil J. Stone, Stanley Wang	2015	12
15	IDDF2019-ABS-0210 Preliminary efficacy and safety of 8-week glecaprevir/pibrentasvir in patients with HCV genotype 1–6 infection and compensated cirrhosis: the EXPEDITION-8 study Robert S. Brown, C. Hézode, Stanley Wang, Marı́a Buti, Wan‐Long Chuang, Humberto Aguilar, Gábor Horváth, Bárbara Rosado Carrión, Federico Rodríguez-Pérez, Eric Cohen, Yiran Hu, Gretja Schnell, Chih‐Wei Lin, Lino Rodrigues, Roger Trinh, Federico Mensa	2019	8
16	Phase 1 study of safety, pharmacokinetics, and antiviral activity of SARS‐CoV‐2 neutralizing monoclonal antibody ABBV‐47D11 in patients with COVID‐19 Pharmacology Research & Perspectives ·Mohamad Shebley, Stanley Wang, Izna Ali, Preethi Krishnan, Rakesh Tripathi, Joseph M. Reardon, John Cafardi, Galia Rahav, Yoseph Caraco, Jihad Slim, Fadi Al Akhrass, Mengjia Yu, Yiran Hu, Rosa De Abreu Ferreira, Negar Niki Alami	2022	6
17	Characterizing complex and competing drug–drug interactions between the antiviral regimen of glecaprevir and pibrentasvir with rifampin or carbamazepine Clinical and Translational Science ·Matthew P. Kosloski, Hong Li, Stanley Wang, Federico Mensa, Jens J. Kort, Wei Liu	2023	4
18	High SVR Rates with Eight and Twelve Weeks of Pangenotypic Glecaprevir/Pibrentasvir: Integrated Efficacy Analysis of Genotype 1-6 Patients Without Cirrhosis Gastroenterology ·Massimo Puoti, Graham R. Foster, Stanley Wang, David Mutimer, Edward Gane, Christophe Moreno, Ting Chang, Sam Lee, Rui Tato Marinho, Jean‐François Dufour, Stanislas Pol, Christophe Hézode, Stuart C. Gordon, Simone I. Strasser, Paul J. Thuluvath, Ran Liu, Edward Tam, Federico Mensa	2017	4
19	Safety, pharmacokinetics, and antiviral activity of single ascending doses of ALG-125755, a GalNAc-conjugated small interfering RNA, in subjects with chronic hepatitis B Journal of Hepatology ·Alina Jucov, Edward Gane, Megan Fitzgerald, Kha Le, Stanley Wang, Lynne Ammar, Chris Burnett, Alexei Haceatrean, Kusum Gupta, D. E. R. Clark, Meenakshi Venkatraman, Leonid Beigelman, Lawrence M. Blatt, Tse‐I Lin, Sushmita Chanda, Matthew W. McClure, John Fry	2023	4
20	752 High SVR Rates With the Combination of ABT-493 + ABT-530 for 8 Weeks in Non-Cirrhotic Patients with HCV Genotype 1 or 2 Infection Gastroenterology ·Fred Poordad, Franco Felizarta, Stanley Wang, Armen Asatryan, Tarek Hassanein, Humberto Aguilar, Jacob Lalezari, J. Scott Overcash, Teresa I. Ng, Sandra Lovell, Chih‐Wei Lin, Jens Kort, Federico Mensa	2016	2

About Stanley Wang

Stanley Wang is a scholar working on Hepatology, Infectious Diseases, Epidemiology, Geriatrics and Gerontology and Health, having authored 28 papers that have together received 898 indexed citations. Recurring topics across this work include Hepatitis C virus research (19 papers), HIV/AIDS drug development and treatment (10 papers), Liver Disease Diagnosis and Treatment (6 papers), Hepatitis B Virus Studies (5 papers), Systemic Lupus Erythematosus Research (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Primary Care and Health Outcomes (2 papers) and Health disparities and outcomes (2 papers). The work is most often cited by research in Hepatology (404 citations), Infectious Diseases (245 citations), Epidemiology (367 citations), Emergency Medical Services (57 citations) and Transplantation (19 citations). Stanley Wang has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Amy E. Wallace, Lewis E. Kazis, William B. Weeks, Austin F. Lee, Federico Mensa, Austin Lee, Shirit Einav, Edward Tam, Edward Gane and Grégory Neveu. Their work appears in journals such as Gastroenterology, Journal of Hepatology, Open Forum Infectious Diseases, Clinical Infectious Diseases and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact